Tocilizumab Treatment in Polyarteritis Nodosa

Isr Med Assoc J. 2019 Aug;21(8):560-562.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Drug Therapy, Combination
  • Humans
  • Male
  • Polyarteritis Nodosa / drug therapy*
  • Polyarteritis Nodosa / immunology
  • Polyarteritis Nodosa / physiopathology
  • Receptors, Interleukin-6 / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • Receptors, Interleukin-6
  • tocilizumab